CL-218,872 EU


Discover CL-218,872 – The Next Generation Sedative

Introducing CL-218,872, a groundbreaking sedative-hypnotic offering unparalleled efficacy in inducing sleep and reducing anxiety. Unlike traditional benzodiazepines, CL-218,872 targets specific GABA A receptors, ensuring a focused approach with fewer side effects. Ideal for research and therapeutic applications, it’s a beacon of hope for those seeking reliable and safe sedation.

This product is available also in Capsule and Drops for an easier research.

All the products from EU Retail can be shipped to EU countries only.

All the designer drugs sold on this website are intended for research and forensic applications.


Product Overview:

CL-218,872 is a novel sedative and hypnotic compound. Unlike traditional benzodiazepines, it belongs to a unique class of nonbenzodiazepine hypnotics. The compound is particularly noted for its selective action on the GABA A receptor, specifically targeting the α1 subtype.

Chemical and Pharmacological Properties:

The molecular structure of CL-218,872 differentiates it from benzodiazepines, contributing to its unique pharmacological profile. Its action as a partial agonist at the GABA A receptor sites leads to sedative, anxiolytic, anticonvulsant, and amnestic effects, with a reduced risk of dependency compared to traditional benzodiazepines.

Dosage and Administration:

The optimal dosage of CL-218,872 varies depending on the intended use and the subject’s physiology. In research settings, dosages are carefully controlled and monitored.

Therapeutic Effects:

CL-218,872 is primarily used in research for its sedative and hypnotic effects. It has shown potential in studies for inducing sleep and reducing anxiety, with a faster onset and shorter duration of action, making it advantageous for specific therapeutic applications.

Side Effects and Harm Reduction:

Like all sedative-hypnotics, CL-218,872 can cause side effects such as dizziness, confusion, and motor impairment. Long-term use or misuse can lead to tolerance and dependence. Its safety profile, however, indicates a lower risk of these adverse effects compared to traditional benzodiazepines. Harm reduction strategies involve controlled administration, monitoring for adverse reactions, and avoiding use with other central nervous system depressants.

Comparative Analysis:

In comparison to other hypnotics like triazolam or zolpidem, CL-218,872 offers a unique balance of efficacy and safety, making it a subject of interest in both pharmacological research and potential clinical use.

Why Buy CL-218,872 EU from RECHEMCO?

★ We have a long trading history in the market so you benefit from our experience.
★ CL-218,872 was tested and verified.
★ We accept various payment methods such as Bitcoin, Monero, many other cryptocurrencies and bank wire.

What you will receive when you buy CL-218,872 EU from RECHEMCO?

• One sealed aluminum foil bag containing highest grade CL-218,872 EU
• White powder
• 98-99% Purity


50mg, 100mg, 250mg, 500mg, 1g


There are no reviews yet.

Be the first to review “CL-218,872 EU”

Your email address will not be published. Required fields are marked *


  • Try your luck and win a discount coupon code
  • 1 free spin every 15 days
  • No cheating! Please use your real email address only.
  • REMEMBER: The validity of the coupon code is 7 days.
Try Your Luck!
Remind later
No thanks